245 related articles for article (PubMed ID: 31034938)
1. In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.
Karlowsky JA; Lagacé-Wiens PRS; Adam HJ; Baxter MR; Laing NM; Walkty AJ; Zhanel GG
Int J Antimicrob Agents; 2019 Jul; 54(1):62-68. PubMed ID: 31034938
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
[TBL] [Abstract][Full Text] [Related]
5. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
6. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan.
Wang JT; Chang SC; Chang FY; Fung CP; Chuang YC; Chen YS; Shiau YR; Tan MC; Wang HY; Lai JF; Huang IW; Yang Lauderdale TL
PLoS One; 2015; 10(12):e0144103. PubMed ID: 26632819
[TBL] [Abstract][Full Text] [Related]
9. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.
Karlowsky JA; Lagacé-Wiens PR; Simner PJ; DeCorby MR; Adam HJ; Walkty A; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2011 Jul; 55(7):3169-75. PubMed ID: 21537027
[TBL] [Abstract][Full Text] [Related]
11. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
12. In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.
Karlowsky JA; Denisuik AJ; Lagacé-Wiens PR; Adam HJ; Baxter MR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2014; 58(2):1252-6. PubMed ID: 24323476
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
Marković T; Jeinić L; Smitran A; Petković M
Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
[TBL] [Abstract][Full Text] [Related]
14. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia.
Ny S; Edquist P; Dumpis U; Gröndahl-Yli-Hannuksela K; Hermes J; Kling AM; Klingeberg A; Kozlov R; Källman O; Lis DO; Pomorska-Wesołowska M; Saule M; Wisell KT; Vuopio J; Palagin I;
J Glob Antimicrob Resist; 2019 Jun; 17():25-34. PubMed ID: 30447337
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]